Market Cap Chart

Historical Market Cap Data

View and export this data back to 2026. Start Trial.
Date Value
November 13, 2026 388.42B
November 12, 2026 386.43B
November 11, 2026 386.27B
November 10, 2026 391.15B
November 09, 2026 392.36B
November 06, 2026 376.69B
November 05, 2026 370.40B
November 04, 2026 385.93B
November 03, 2026 383.67B
November 02, 2026 386.43B
October 30, 2026 386.97B
October 29, 2026 388.30B
October 28, 2026 388.44B
October 27, 2026 382.93B
October 26, 2026 374.52B
October 23, 2026 385.85B
October 22, 2026 372.13B
October 21, 2026 371.91B
October 20, 2026 378.46B
October 19, 2026 364.99B
October 16, 2026 364.40B
October 15, 2026 364.15B
October 14, 2026 357.07B
October 13, 2026 349.04B
October 12, 2026 342.86B
Date Value
October 09, 2026 345.90B
October 08, 2026 339.25B
October 07, 2026 343.97B
October 06, 2026 340.52B
October 05, 2026 340.93B
October 02, 2026 341.19B
October 01, 2026 352.65B
September 30, 2026 330.64B
September 29, 2026 343.85B
September 28, 2026 354.26B
September 25, 2026 355.38B
September 24, 2026 344.83B
September 23, 2026 347.52B
September 22, 2026 354.56B
September 21, 2026 353.21B
September 18, 2026 346.24B
September 17, 2026 351.94B
September 16, 2026 337.16B
September 15, 2026 359.52B
September 14, 2026 353.54B
September 11, 2026 343.23B
September 10, 2026 338.43B
September 09, 2026 340.96B
September 08, 2026 350.23B
September 04, 2026 352.31B

Market Capitalization Definition

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.

Read full definition.

Market Cap Range, Past 5 Years

View Market Cap Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Benchmarks

View Market Cap Benchmarks
Start Trial
Novartis AG 303.12B
Addex Therapeutics Ltd. 4.311M
Oculis Holding AG 473.07M
Sandoz Group AG 43.60B
Galderma Group AG 53.23B

Market Cap Related Metrics

PE Ratio 45.05
PS Ratio 5.109
Price 487.50
Earnings Yield 2.22%
Operating PE Ratio 16.66